Literature DB >> 32758461

First case of osteosarcoma in a dinosaur: a multimodal diagnosis.

Seper Ekhtiari1, Kentaro Chiba2, Snezana Popovic3, Rhianne Crowther4, Gregory Wohl5, Andy Kin On Wong6, Darren H Tanke7, Danielle M Dufault8, Olivia D Geen3, Naveen Parasu9, Mark A Crowther3, David C Evans10.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32758461     DOI： 10.1016/S1470-2045(20)30171-6

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  5 in total

1.  Increased risk of cancer in dogs and humans: a consequence of recent extension of lifespan beyond evolutionarily-determined limitations?

Authors:  Aaron L Sarver; Kelly M Makielski; Taylor A DePauw; Ashley J Schulte; Jaime F Modiano
Journal:  Aging Cancer       Date:  2022-02-23

2.  Description and etiology of paleopathological lesions in the type specimen of Parasaurolophus walkeri (Dinosauria: Hadrosauridae), with proposed reconstructions of the nuchal ligament.

Authors:  Filippo Bertozzo; Fabio Manucci; Matthew Dempsey; Darren H Tanke; David C Evans; Alastair Ruffell; Eileen Murphy
Journal:  J Anat       Date:  2020-12-01       Impact factor: 2.610

3.  A simple, universal and multifunctional template agent for personalized treatment of bone tumors.

Authors:  Wei-Bo Liu; Su-He Dong; Wen-Hao Hu; Meng Gao; Teng Li; Quan-Bo Ji; Xiao-Qing Yang; Deng-Bin Qi; Zhen Zhang; Ze-Long Song; Yu-Jie Liu; Xue-Song Zhang
Journal:  Bioact Mater       Date:  2021-10-26

4.  The first occurrence of an avian-style respiratory infection in a non-avian dinosaur.

Authors:  D Cary Woodruff; Ewan D S Wolff; Mathew J Wedel; Sophie Dennison; Lawrence M Witmer
Journal:  Sci Rep       Date:  2022-02-10       Impact factor: 4.379

5.  Single-Cell Profiling of Tumor Microenvironment Heterogeneity in Osteosarcoma Identifies a Highly Invasive Subcluster for Predicting Prognosis.

Authors:  Junfeng Guo; Hong Tang; Pan Huang; Junfeng Guo; Youxing Shi; Chengsong Yuan; Taotao Liang; Kanglai Tang
Journal:  Front Oncol       Date:  2022-04-06       Impact factor: 5.738
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.